Eczema affects roughly 17 percent of Canadians at some point in their lives, according to the Canadian Dermatology Association. For many, it is a chronic condition marked by dry, inflamed, intensely itchy skin that flares unpredictably and resists easy management.
It is no surprise that more Canadians are asking whether CBD oil might offer some skin relief alongside their existing treatments. This guide looks honestly at what early research suggests, how cannabidiol interacts with your skin’s biology, and what you need to think about before trying it. This content is for educational purposes only and is not medical advice.
Canadian Cannabinoid Honesty Scorecard
| Claimed Benefit | Evidence Level | Source |
|---|---|---|
| CBD may reduce skin inflammation linked to eczema | Studied in Animals or Lab | Oláh et al., 2014, Journal of Clinical Investigation |
| CBD may support the skin barrier and reduce dryness | Studied in Animals or Lab | Tóth et al., 2019, Experimental Dermatology |
| CBD may reduce itch sensation through nerve pathways | Studied in Animals or Lab | Szepietowski et al., 2019, Acta Dermato Venereologica |
| CBD topicals reduce eczema severity in humans | Clinically Studied in Humans (small trials) | Palmieri et al., 2019, Clinical Therapeutics |
| CBD cures or permanently clears eczema | Anecdotal | No evidence supports this claim as of 2025 |
| CBD reduces long term eczema recurrence | Anecdotal | No long term human trial data available as of 2025 |
Evidence levels: Clinically Studied in Humans / Studied in Animals or Lab / Traditional/Observational Use / Anecdotal
How Does CBD Interact With Your Skin at a Biological Level?
Your skin is not just a passive outer layer. It is an active immune and regulatory organ with its own endocannabinoid system. CB1 and CB2 receptors, the two primary receptors of the endocannabinoid system, are found throughout the skin in keratinocytes, immune cells, sebaceous glands, and sensory nerve endings. This means your skin is genuinely capable of responding to cannabinoids applied directly to its surface.
In eczema, the skin barrier is compromised. The outermost layer of the skin, called the stratum corneum, fails to hold moisture properly and allows environmental irritants and allergens to penetrate more easily. This triggers an immune response that leads to inflammation, itching, and the characteristic redness of an eczema flare.
A 2019 study in Experimental Dermatology by Tóth and colleagues found that CBD influenced lipid production in skin cells in ways that could be relevant to skin barrier function, though the authors were careful to note that human clinical translation was still needed.
CBD also appears to interact with TRPV1 receptors in the skin, which are involved in the sensation of itch and pain. A 2019 study in Acta Dermato Venereologica by Szepietowski and colleagues found that a cannabinoid enriched cream significantly reduced itch severity in patients with chronic pruritus, a condition that shares mechanisms with eczema related itching. This is one of the more clinically relevant findings for eczema sufferers because itch is often the most disruptive daily symptom.
For those using ingestible CBD alongside a topical, full spectrum oil keeps the full plant profile including terpenes and trace THC within Canada’s legal limits, which may offer broader systemic support through the entourage effect. Broad spectrum removes THC while keeping other plant compounds. Isolate is pure CBD alone.
CBD Oil Collection
Topical CBD vs Ingestible CBD: Which Approach Makes Sense for Eczema?
This is one of the most practical questions Canadian eczema sufferers ask, and it deserves a clear answer.
Topical CBD applied directly to affected skin areas is the most targeted approach. It does not enter the bloodstream in meaningful amounts. Instead it works locally at the site of application, interacting with the skin’s own endocannabinoid receptors.
A small 2019 clinical trial published in Clinical Therapeutics by Palmieri and colleagues found that a CBD enriched skin ointment improved skin parameters including hydration, elasticity, and the appearance of inflammatory skin conditions including eczema, after just eight weeks of twice daily application. This is one of the few human studies with results directly relevant to eczema.
Ingestible CBD oil taken under the tongue works systemically, meaning it affects the whole body rather than one skin area. For eczema sufferers whose flares are closely linked to stress, anxiety, or poor sleep, ingestible CBD may offer support by addressing those underlying triggers rather than the skin symptoms directly. Many users find a combined approach most useful, a topical for local skin support and an oral oil for systemic calm.
CBDNorth’s topical range, including the CBD body pain balm and pain roller, can be explored as part of a skin support approach. For ingestible options and to understand which format suits your routine, the CBD Dosage Chart gives a practical Canadian framed starting guide. Most adults begin with 10 to 25 mg of ingestible CBD and adjust gradually.
What Canadians With Eczema Are Actually Asking About CBD
The three concerns that come up most consistently are itch relief, moisture retention, and reducing the frequency or severity of flares.
On itch, the early research is probably the most encouraging signal. The TRPV1 receptor connection and the clinical study on chronic pruritic conditions both suggest that CBD applied topically may reduce the urgency and intensity of the itch response for some users. Anecdotal evidence from Canadian users supports this, though individual responses vary considerably based on eczema type, skin sensitivity, and which triggers drive a person’s flares.
On moisture and skin barrier support, the lipid research from Tóth and colleagues is interesting because one of the core problems in eczema is inadequate natural oil production in the skin barrier. Early evidence suggests CBD may influence this process. However, this remains animal and lab based evidence and has not yet been confirmed in large scale human trials for eczema specifically.
On flare frequency, this is where the honest answer is least satisfying. No long term controlled study has followed eczema patients using CBD over months or years to measure whether it reduces how often flares occur. What users report is observational. Some notice patterns that suggest CBD is helping. Others see no meaningful change. Both outcomes are possible and neither is surprising given the complexity of eczema as a condition.
Full Spectrum vs Broad Spectrum vs Isolate for Skin Conditions
| Type | What Is In It | THC Content in Canada | Entourage Effect | Best For |
|---|---|---|---|---|
| Full Spectrum | All cannabinoids, terpenes, and flavonoids | Up to 1% (Canada allows up to 1%, higher than the US 0.3% limit) | Yes, full plant synergy | Those wanting the broadest ECS support for skin and systemic calm |
| Broad Spectrum | Multiple cannabinoids and terpenes, THC removed | Undetectable | Partial synergy | THC sensitive users who still want plant compound variety |
| Isolate | Pure CBD only | Zero | None | Those with very reactive skin who want the simplest possible formula |
Canada allows up to 1% THC in cannabis products. For topical use, THC content is less likely to be a drug testing concern since it does not enter the bloodstream meaningfully. Always check your product’s Certificate of Analysis.
Onset and Duration Timeline: CBD for Eczema Support
| Time Point | CBD Topical Applied to Skin | CBD Oil Sublingual |
|---|---|---|
| T+15 min | Some users notice early reduction in itch sensation | Some users notice early calming or settling |
| T+30 min | Local skin effect becoming noticeable for many | Onset beginning for many users |
| T+1 hr | Peak local effect for most users | Peak systemic calming effect for most |
| T+2 hrs | Effects sustained; skin feels more settled | Effects sustained |
| T+4 hrs | Gradual fading of local effect for some | Gradual tapering for some |
| T+6 to 8 hrs | Reapplication may be needed for ongoing support | Most effects have faded; body weight affects duration |
Individual responses vary significantly with eczema because skin sensitivity, flare severity, and trigger factors differ from person to person. These timelines are general patterns and not guaranteed outcomes.
Who Should NOT Use CBD for Eczema?
This section is mandatory and we never skip it.
Pregnancy and breastfeeding: Health Canada advises against using any cannabis product during pregnancy or while breastfeeding. This applies to both topical and ingestible CBD. Pregnant or nursing women should manage skin conditions under medical guidance only.
Children and youth: CBD products are intended for adults aged 18 and older. Age minimums vary by province from 18 to 21. Eczema is common in children, but CBD products should never be used on children without specialist medical guidance. These products are made for adults.
People with known cannabis or hemp allergies: If you have a confirmed allergy to cannabis, hemp, or plants in the Cannabaceae family, do not use CBD topicals or ingestible products. Allergic contact dermatitis from hemp derived products can worsen skin conditions significantly.
People taking prescription eczema treatments through the CYP450 pathway: Ingestible CBD affects the liver enzyme system that processes many medications including some immunosuppressants and biologics used for moderate to severe eczema. This interaction is documented in peer reviewed research by Zendulka et al., 2016, Current Drug Metabolism. If you take prescription eczema medication, speak with your dermatologist or pharmacist before adding CBD.
People with open or infected skin: Never apply any topical product, including CBD balm, to open wounds, actively infected skin, or weeping eczema lesions. Always allow the skin to heal before introducing new topical products.
Liver conditions: High dose ingestible CBD has shown liver enzyme changes in some clinical studies. If you have an existing liver condition, consult your doctor before use.
Scheduled surgery: Some healthcare practitioners recommend stopping CBD at least two weeks before any planned surgical procedure due to possible effects on blood clotting and anaesthesia.
What We Don’t Know Yet: Honest Research Gaps
- The largest human clinical study on CBD topicals for eczema to date involved fewer than 30 participants and ran for only eight weeks. This is encouraging as a pilot signal but nowhere near enough evidence to draw confident conclusions about effectiveness or safety for long term eczema management.
- No study as of 2025 has directly compared a CBD topical against a conventional eczema treatment such as a corticosteroid cream or tacrolimus ointment in a controlled head to head trial. Until that comparison is made, we cannot say how CBD stacks up against existing treatments.
- The optimal concentration of CBD in a topical for eczema is not yet established. Products on the Canadian market vary enormously in CBD concentration, carrier ingredients, and formulation, and no clinical guideline yet exists to help consumers compare them meaningfully.
- Health Canada’s Natural Health Product pathway for CBD remains under active consultation as of 2025. The regulatory framework for CBD products with health adjacent claims continues to evolve and is not yet settled.
- It is not yet known whether the type of eczema, atopic, contact, seborrhoeic, or nummular, responds differently to CBD. These are meaningfully different conditions that share the eczema label but have distinct underlying mechanisms.
Province by Province Access Snapshot
| Province | Minimum Age | CBDNorth Ships Here | Notes |
|---|---|---|---|
| British Columbia | 19 | Yes | Cannabis Act governs; provincial retailers regulated separately |
| Alberta | 18 | Yes | Lowest provincial minimum age in Canada |
| Ontario | 19 | Yes | AGCO regulates provincial retail |
| Quebec | 21 | Yes | Highest provincial minimum age in Canada |
| Manitoba | 19 | Yes | Standard federal framework applies |
| Saskatchewan | 19 | Yes | Standard federal framework applies |
| Nova Scotia | 19 | Yes | Standard federal framework applies |
| New Brunswick | 19 | Yes | Standard federal framework applies |
| Prince Edward Island | 19 | Yes | Standard federal framework applies |
| Newfoundland | 20 | Yes | Slightly above federal minimum |
| Territories (YT, NT, NU) | 19 | Yes | Varies slightly by territory |
Last Verified: April 2026. Always confirm current rules at canada.ca/health-canada. Provincial rules can and do change.
Real Canadian User Experience Log
The following logs are shared with full user consent. Individual results vary. These are personal experience reports and not medical outcomes.
| Week | Serving | Timing | Reported Effect | Notes |
|---|---|---|---|---|
| Week 1 | CBD balm applied to forearm and back of knee | Twice daily after shower | Noticed reduced urge to scratch within a few days; skin felt less tight | Chosen over ingestible format as first step; existing moisturiser still used |
| Week 2 | CBD balm twice daily continued | Morning and evening | Skin looked less red around treated areas; itching at night reduced noticeably | No changes to diet or other skincare routine |
| Week 1 | 0.5 mL CBD oil (15 mg) sublingual | Morning daily | No strong skin effect in first week; sleep felt more settled | Primary concern was stress driven flares and poor sleep |
| Week 3 | 0.5 mL CBD oil (15 mg) sublingual | Morning daily | Fewer flare days reported; attributed partly to feeling less anxious overall | Still using prescribed emollient alongside CBD oil |
| Week 4 | CBD balm plus 0.5 mL oil combined | Morning and evening | Preferred the combined approach; local skin support plus systemic calm felt complementary | Dermatologist aware of CBD use and monitoring skin progress |
C.N., Ontario; B.R., Alberta; T.L., British Columbia. Experience logs reflect personal responses and are not predictive of your results. These are not medical outcomes.
CBDNorth Lab Note
For anyone applying CBD directly to already sensitive or compromised skin, ingredient quality is not a minor detail. It is everything. Every CBDNorth product is tested batch by batch at an ISO certified Canadian laboratory, with full panel results covering cannabinoid content, pesticides, heavy metals, and residual solvents published openly on our lab reports page.
Our hemp is USDA organic certified and extracted using supercritical CO2 at every stage, which means no harsh solvent residues in anything that touches your skin. If the cost of accessing CBD skincare is a barrier for you, our Assistance Program is available for Canadians who qualify.
Before adding any new topical or ingestible product to your eczema management routine, especially if you use prescription skin treatments or have a complex skin history, please speak with a qualified healthcare practitioner or dermatologist.
Frequently Asked Questions
Q: Can CBD oil help with eczema flare ups in Canada?
Early research, including a small 2019 human trial in Clinical Therapeutics, found that a CBD enriched skin ointment improved skin hydration, elasticity, and inflammatory markers in participants with conditions including eczema after eight weeks of twice daily use. Some Canadians also report that ingestible CBD helps by reducing the stress and sleep disruption that trigger their flares. No large scale human trial has confirmed these benefits, and CBD cannot legally be claimed to treat eczema under Canada’s Cannabis Act.
Q: Should I use a CBD topical or CBD oil for eczema?
Both have a role depending on your needs. A CBD topical applied directly to affected skin works locally at the site of inflammation and itch without entering the bloodstream. CBD oil taken under the tongue works systemically and may help with stress or sleep triggers that worsen flares. Many users find a combined approach most useful. If you are new to CBD, starting with one format for two to four weeks before adding the other makes it easier to understand which is helping.
Q: Is CBD safe to use on sensitive or broken skin?
CBD topicals should never be applied to open wounds, actively infected skin, or actively weeping eczema lesions. Once the skin surface is intact, even if still dry or slightly inflamed, many users apply CBD balm or oil without issue. If you have a history of allergic contact dermatitis or known sensitivities to plant based products, do a small patch test on an unaffected area first and wait 24 hours before applying more broadly.
Q: How much CBD should I use for eczema?
For topicals, the amount depends on the size of the affected area and the concentration of your product. Apply a thin even layer to the affected skin twice daily and assess the response over two to four weeks. For ingestible CBD taken alongside a topical, most Canadian adults start with 10 to 25 mg per day. CBDNorth’s CBD Dosage Chart gives a practical starting framework for ingestible use.
Q: Can CBD interact with my eczema prescription?
Ingestible CBD affects the CYP450 liver enzyme pathway, which processes several medications used for moderate to severe eczema including some immunosuppressants and biological therapies. If you take any prescription treatment for eczema, speak with your dermatologist or pharmacist before adding ingestible CBD to your routine. CBD topicals applied to the skin do not enter the bloodstream in meaningful amounts and are generally considered lower risk for drug interactions, but your prescriber should still be aware of everything you are using.
Q: Is CBD legal for eczema support in Canada?
Yes. CBD products fall under Canada’s Cannabis Act and can be legally purchased by adults from licensed retailers or reputable online brands. No CBD product can legally claim to treat eczema in Canada. The minimum purchase age ranges from 18 to 21 depending on your province. Health Canada’s Natural Health Product pathway for CBD remains under active consultation as of 2025.
Before starting any new wellness supplement or topical, please speak with a qualified healthcare practitioner or dermatologist, especially if you manage eczema alongside other skin conditions or take prescription medications.
These statements have not been evaluated by Health Canada. CBDNorth products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. This content is for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare practitioner before use. Must be 18 and older to purchase; age requirements vary by province.
